Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts
- PMID: 18957529
- PMCID: PMC2628703
- DOI: 10.2337/dc08-1625
Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts
Abstract
Objective: The purpose of this study was to investigate the role of circulating resistin levels in the development of type 2 diabetes using two prospective cohorts of well-characterized men and women.
Research design and methods: We conducted two prospective case-control studies nested in the Women's Health Study (WHS) and Physicians' Health Study II (PHS II). In the WHS, during a median of 10-years of follow-up, 359 postmenopausal women, who were apparently healthy at baseline and later developed type 2 diabetes, were prospectively matched with 359 healthy control subjects. In the PHS II, with 8 years of total follow-up, 170 men, who were apparently healthy at baseline and later developed type 2 diabetes, were matched with 170 healthy control subjects. Control subjects were matched by age, race, and time of blood draw.
Results: Resistin levels at baseline were significantly higher in women than in men (P = 0.003) and in case patients than in control subjects for both women (P < 0.001) and men (P = 0.07). After adjustment for matching factors, physical activity, alcohol intake, smoking, and family history of diabetes, the relative risk of type 2 diabetes comparing the highest to the lowest quartile of resistin in women was 2.22 ([95% CI 1.32-3.73]; Ptrend = 0.002). This association was attenuated after further adjustment for BMI (1.51 [0.86-2.65]; Ptrend = 0.20) or C-reactive protein (1.18 [0.68-2.07]; Ptrend = 0.60). A similar but weaker pattern was observed in men.
Conclusions: Elevated levels of circulating resistin were significantly related to increased risk of type 2 diabetes, which appears to be partially accounted for by adiposity and the inflammatory process.
References
-
- Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 409:307–312, 2001 - PubMed
-
- Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA: Regulation of fasted blood glucose by resistin. Science 303:1195–1198, 2004 - PubMed
-
- Tokuyama Y, Osawa H, Ishizuka T, Onuma H, Matsui K, Egashira T, Makino H, Kanatsuka A: Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism 56:693–698, 2007 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA-40360/CA/NCI NIH HHS/United States
- CA-34944/CA/NCI NIH HHS/United States
- HL-34595/HL/NHLBI NIH HHS/United States
- HL 043851/HL/NHLBI NIH HHS/United States
- R01 HL043851/HL/NHLBI NIH HHS/United States
- T32 HG002536/HG/NHGRI NIH HHS/United States
- CA 047988/CA/NCI NIH HHS/United States
- R01 HL026490/HL/NHLBI NIH HHS/United States
- R01 CA047988/CA/NCI NIH HHS/United States
- CA-097193/CA/NCI NIH HHS/United States
- R01 CA097193/CA/NCI NIH HHS/United States
- R01 CA034944/CA/NCI NIH HHS/United States
- K01-DK078846/DK/NIDDK NIH HHS/United States
- HL-26490/HL/NHLBI NIH HHS/United States
- HL 080467/HL/NHLBI NIH HHS/United States
- R01 HL034595/HL/NHLBI NIH HHS/United States
- DK066401/DK/NIDDK NIH HHS/United States
- R01 HL080467/HL/NHLBI NIH HHS/United States
- R01 DK066401/DK/NIDDK NIH HHS/United States
- R01 CA040360/CA/NCI NIH HHS/United States
- K01 DK078846/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials